Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models
Nalini R. Rao, Olivia A. DeGulis, Toshihiro Nomura…·Jeffrey N. Savas
The paper discovers that levetiracetam prevents Aβ42 production by modulating synaptic vesicle cycling, altering APP localization, and favoring non-amyloidogenic processing in Alzheimer's disease models.